Live price temporarily unavailable.
BioAtla (BCAB) is a Health Care company. Latest news and coverage below.
| FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | — | — | $300.0K | — | — | — | — |
| Operating income | −$28.3M | −$30.1M | −$96.4M | −$108.1M | −$129.7M | −$73.9M | −$59.3M |
| Operating margin | — | — | −32146.7% | — | — | — | — |
| Net income | −$29.9M | −$35.9M | −$95.4M | −$106.5M | −$123.5M | −$69.8M | −$59.6M |
| Net margin | — | — | −31800.7% | — | — | — | — |
| EPS (diluted) | — | −$7975.00 | −$138.00 | −$137.00 | −$129.00 | −$72.00 | −$50.50 |
| Balance sheet | |||||||
| Cash and equivalents | $3.70M | $238.6M | $245.0M | $215.5M | $111.5M | $49.0M | $7.12M |
| Total assets | — | $244.9M | $254.4M | $225.7M | $119.7M | $52.4M | $13.8M |
| Total liabilities | — | $35.0M | $43.6M | $45.4M | $49.0M | $38.2M | $50.0M |
| Shareholders' equity | −$56.0M | $210.0M | $210.8M | $180.3M | $70.7M | $14.3M | −$36.2M |
| Cash flow | |||||||
| Operating cash flow | −$9.64M | −$36.3M | −$62.2M | −$90.4M | −$104.0M | −$71.9M | −$48.2M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$11.3M | −$16.2M | −$17.6M | −$18.6M | −$13.8M | −$9.26M | −$9.31M | $227.0K |
| Net income | −$10.6M | −$14.9M | −$15.3M | −$18.7M | −$15.8M | −$9.78M | −$6.34M | $452.0K |
| EPS (diluted) | −$11.00 | −$15.00 | −$13.16 | −$15.99 | −$13.50 | −$7.85 | −$4.22 | $0.27 |
| Balance sheet | ||||||||
| Cash and equivalents | $56.5M | $49.0M | $32.4M | $18.2M | $8.32M | $7.12M | $1.96M | $1.54M |
| Total assets | $62.2M | $52.4M | $38.3M | $27.1M | $15.9M | $13.8M | $8.57M | $9.51M |
| Total liabilities | $39.3M | $38.2M | $37.7M | $43.9M | $47.1M | $50.0M | $45.9M | $45.7M |
| Shareholders' equity | $23.0M | $14.3M | $547.0K | −$16.7M | −$31.2M | −$36.2M | −$37.3M | −$36.2M |
| Cash flow | ||||||||
| Operating cash flow | −$5.13M | −$16.8M | −$16.3M | −$14.1M | −$9.88M | −$7.92M | −$5.27M | −$419.0K |
From BioAtla's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning BioAtla in our feed yet.